That's what I heard too. The FDA has made a decision on which format they want to see the clinical data, and that decision was communicated to CytoDyn about ten days ago. In that case, the company should be good to go for getting the clinical portion of the BLA in this month. Manufacturing portion is significantly out of their hands, but they hope to and believe that can be in this month as well.